AdvaMed has made President and CEO Nadim Yared chairman of the AdvaMed board for a two-year term. Yared has served on the AdvaMed board since 2011 and on the board of AdvaMed Accel since its inception in 2012.
Motus GI has appointed Samuel R. Nussbaum, M.D., to its board of directors. Dr. Nussbaum is a strategic consultant to EBG Advisors and a senior advisor to Sandbox Industries. He is a professor of clinical medicine at Washington University School of Medicine, an adjunct professor at the Olin School of Business, Washington University and a senior fellow at the University of Southern California Schaeffer Center for Health Policy and Economics.
SPR Therapeutics has named Michael P. Chuisano to its board of directors. Chuisano is vice president and chief operating officer for Johnson & Johnson Innovation-JJDC where he has served in various roles over three decades. In July 2016, SPR received clearance from the FDA for its SPRINT peripheral nerve stimulation system for relief of chronic and acute pain.